Both in Pharmaceuticals
BridgeBio Pharma vs BioMarin Pharmaceuticals
Over the past year BBIO returned +20.4% and BMRN returned +4.2%; their daily moves had a correlation of 0.26.
BBIO +20.4% BMRN +4.2%Growth of $1, one year, split-adjusted
| Metric | BBIO | BMRN |
|---|---|---|
| Price | $74.63 | $55.06 |
| Market cap | $14.54B | $10.66B |
| Today | −0.49% | −4.14% |
| 1 month | +12.8% | −4.3% |
| 6 months | +8.5% | +3.4% |
| Year to date | −2.4% | −7.4% |
| 1 year | +19.1% | +2.8% |
| Revenue growth (YoY) | +192.6% | +19.9% |
| Gross margin | 94.2% | 79.5% |
| Net margin | −23.5% | 4.5% |
| P/E (TTM) | — | 146.1× |
| Price / sales | 15.4× | 3.1× |
| Net cash | -$938.6M | -$3.31B |
| Dividend yield | — | — |
| Volatility (60d) | 32.4% | 27.2% |
| Short % of float | 12.5% | 6.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).